Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: An overview

Pharmacotherapy

Volumn 25, Issue 12 I, 2005, Pages 1687-1707

  Bailie, George R ^a   Massry, Shaul G ^b  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bone disease; Bone metabolism; Chronic kidney disease; CKD; K DOQI; Kidney Disease Outcomes Quality Initiative; National Kidney Foundation; Nephrology clinical practice guidelines

Indexed keywords

ALFACALCIDOL; ALLOBARBITAL; ALTERNAGEL; ALU TAB; ALUMINUM; ALUMINUM HYDROXIDE; ALUMINUM HYDROXYCARBONATE; CALCI CHEW; CALCI MIX; CALCITRIOL; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; CITRATE CALCIUM; DOXERCALCIFEROL; ERGOCALCIFEROL DERIVATIVE; LANTHANUM CARBONATE; MAGNEBIND; MAGNESIUM CARBONATE; PARICALCITOL; PHOSPHATE BINDING AGENT; SEVELAMER; TITRALAC; TUMS; VITAMIN D; VITAMIN D DERIVATIVE;

ALUMINUM OVERLOAD; ANEMIA; BONE DISEASE; BONE METABOLISM; BONE MINERALIZATION; CALCIUM METABOLISM; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONSTIPATION; DIALYSIS ENCEPHALOPATHY; DISEASE ASSOCIATION; FECES IMPACTION; GASTROINTESTINAL SYMPTOM; HEALTH CARE QUALITY; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; META ANALYSIS; MICROCYTIC ANEMIA; MORBIDITY; MORTALITY; NAUSEA; NEUROTOXICITY; OSTEOMALACIA; OUTCOMES RESEARCH; PARATHYROID HORMONE RELEASE; PHOSPHATE METABOLISM; PRACTICE GUIDELINE; REVIEW; SOFT TISSUE CALCIFICATION; SYSTEMATIC REVIEW; TASTE DISORDER; VITAMIN D DEFICIENCY; VOMITING;

ALUMINUM; BONE AND BONES; BONE DISEASES, METABOLIC; CALCINOSIS; CALCITRIOL; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; HYPOCALCEMIA; KIDNEY FAILURE, CHRONIC; MINERALS; PRACTICE GUIDELINES; VITAMIN D DEFICIENCY;

EID: 29044435739     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.2005.25.12.1687     Document Type: Review

References (14)

1. Bailie GR. From dialysis outcomes quality initiative to kidney disease outcomes quality initiative: new clinical practice guidelines in nephrology - what the practicing pharmacist needs to know. Pharmacotherapy 2004;24:551-7.
2. Bailie GR, Uhlig K, Levey AS. Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease. Pharmacotherapy 2005;25:491-502.
3. National Kidney Foundation. K/DOQ1 clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1-201. Available from http://www.kidney.org/professionals/kdoqi/ guidelines_bone/index.htm. Accessed August 30, 2005.
4. Cozzolino M, Dusso AS, Slatopolsky E. Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 2001;12:2511-16.
5. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-18.
6. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-17.
7. Martin KJ, Olgaard K. Diagnosis, assessment and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 2004;43:558-65.
8. Goodman WG, London G. Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004;43:572-9.
9. Forget D, Caranhac G, Quillot MJ, Besnier MO. Compliance with very low protein diet and ketoanalogues in chronic renal failure. The French multicentric trial IRCCA. Contrib Nephrol 1990;81:79-86.
10. Milas NC, Norwalk MP, Apkele L, et al. Factors associated with adherence to the dietary protein intervention in the modification of diet in renal disease study. J Am Diet Assoc 1995;95:1295-300.
11. Cleary DJ, Matzke GR, Alexander AC, Joy MS. Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health-Syst Pharm 1995;52:1895-900.
12. Grabe DW, Bailie GR, Eisele G, Low CL. Hemodialysis patients' knowledge of their phosphate binder therapy. J Appl Ther Res 1998;2:125-32.
13. Boelart JR, Fenves AZ, Coburn JW. Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis 1991;18:660-7.
14. Ravelli M, Scaroni P, Mombelloni S, et al. Acute visual disorders in patients on regular dialysis given desferrioxamine as a test. Nephrol Dial Transplant 1990;5:945-9.